🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas A. Ciulla

Norwich Research Park

ORCID: 0000-0001-5557-6777

Also affiliated with Improvement Service, Midwest Eye Institute, National Opinion Research Center, University School, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis, Indiana University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.561Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Effect of Race and Insurance Status on Treatment and Outcomes in Diabetic Retinopathy: Analysis of 43 274 Eyes Using the IRIS Registry

Journal of VitreoRetinal Diseases(2024)10.1177/24741264231221607
Top 35%
0.561DataRank
Top 35%9 citations

Vikas Maturi, Adrienne W. Scott, Kathryn A. Carson, Thomas A. Ciulla, Raj K. Maturi +1 more

Papers

Driven by 12 papers — median percentile 65. Top paper: “Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications”.

Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications

Annals of Medicine(2022)10.1080/07853890.2021.1955146
N/A
1.6DataRank · unranked
62 citations

Alon Harris, Ryan Zukerman, Brent Siesky, Francesco Oddone, Alice Verticchio Vercellin +2 more

Effect of Race and Insurance Status on Treatment and Outcomes in Diabetic Retinopathy: Analysis of 43 274 Eyes Using the IRIS Registry

Journal of VitreoRetinal Diseases(2024)10.1177/24741264231221607
Top 35%
0.561DataRank
Top 35%9 citations

Vikas Maturi, Adrienne W. Scott, Kathryn A. Carson, Thomas A. Ciulla, Raj K. Maturi +1 more

Anti-integrin therapy for retinovascular diseases

Expert Opinion on Investigational Drugs(2020)10.1080/13543784.2020.1795639
N/A
0DataRank · unranked
56 citations

Viral Kansara, Qianyi Luo, Thomas A. Ciulla, Ashay D. Bhatwadekar

RNA therapeutics for retinal diseases

Expert Opinion on Biological Therapy(2020)10.1080/14712598.2021.1856365
N/A
0DataRank · unranked
40 citations

Ashay D. Bhatwadekar, Thomas A. Ciulla, Michael Gemayel

Host immune responses after suprachoroidal delivery of AAV8 in nonhuman primate eyes

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.25.313676
N/A
0DataRank · unranked
12 citations

Iris Natalie Mollhoff, Alaknanda Mishra, Tzu-Ni Sin, Taylor Ngo, Thomas A. Ciulla +4 more

Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World

Genes(2021)10.3390/genes12081200
N/A
0DataRank · unranked
71 citations

Aumer Shughoury, Ameya Belamkar, Thomas A. Ciulla, Ashay D. Bhatwadekar

Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis

Ophthalmology(2020)10.1016/j.ophtha.2020.01.006
N/A
0DataRank · unranked
180 citations

Rahul N. Khurana, Milan Shah, Christopher R. Henry, Robert C. Wang, Jennifer Kissner +3 more

Challenges of Cost-Effectiveness Analyses of Novel Therapeutics for Inherited Retinal Diseases

American Journal of Ophthalmology(2021)10.1016/j.ajo.2021.08.009
N/A
0DataRank · unranked
20 citations

Rebhi Abuzaitoun, Gabrielle D. Lacy, Maria Fernanda Abalem, Gregory M. Saltzman, Thomas A. Ciulla +2 more

Disease progression pathways of wet AMD: opportunities for new target discovery

Expert Opinion on Therapeutic Targets(2022)10.1080/14728222.2022.2030706
N/A
0DataRank · unranked
44 citations

Alon Harris, Francesco Oddone, Brent Siesky, Alice Verticchio Vercellin, Thomas A. Ciulla +1 more

Aging Effects on Optic Nerve Neurodegeneration

International Journal of Molecular Sciences(2023)10.3390/ijms24032573
N/A
0DataRank · unranked
40 citations

Alon Harris, Bo Chen, Jing Zhou, Thomas A. Ciulla, Alice Verticchio +4 more

Glaucoma Heritability: Molecular Mechanisms of Disease

Genes(2021)10.3390/genes12081135
N/A
0DataRank · unranked
50 citations

Alon Harris, Francesco Oddone, Brent Siesky, Alice Verticchio Vercellin, Thomas A. Ciulla +1 more

Molecular Genetics of Glaucoma: Subtype and Ethnicity Considerations

Genes(2020)10.3390/genes12010055
N/A
0DataRank · unranked
89 citations

Alon Harris, Alice Verticchio Vercellin, Brent Siesky, Louis R. Pasquale, Thomas A. Ciulla +1 more